Viking Therapeutics Inc (VKTX)

Oct 25, 2025

Heatmap analysis for Viking Therapeutics Inc. and competitorsEarnings Performance Report & Weekly Setup with High ROI Potential - newser.com

Oct 25, 2025

Oct 25, 2025

How hedge fund analytics apply to Viking Therapeutics Inc. stockWeekly Market Report & High Yield Stock Recommendations - newser.com

Oct 25, 2025

Oct 25, 2025

Live market analysis of Viking Therapeutics Inc.2025 Dividend Review & Technical Entry and Exit Alerts - newser.com

Oct 25, 2025

Oct 25, 2025

What makes Viking Therapeutics Inc. stock attractive to growth fundsTrade Risk Assessment & Proven Capital Preservation Methods - newser.com

Oct 25, 2025

Oct 25, 2025

Can trapped investors hope for a rebound in Viking Therapeutics Inc.2025 Sector Review & Fast Exit/Entry Strategy Plans - newser.com

Oct 25, 2025

Oct 25, 2025

Can Viking Therapeutics Inc. stock hit record highs again2025 Volatility Report & Free Technical Confirmation Trade Alerts - newser.com

Oct 25, 2025

Oct 25, 2025

Viking Therapeutics (VKTX) Receives a Rating Update from a Top Analyst - The Globe and Mail

Oct 25, 2025

Oct 25, 2025

Can Viking Therapeutics Inc. (1VT) stock sustain margin levelsJuly 2025 Volume & Stepwise Swing Trade Plans - newser.com

Oct 25, 2025

Oct 25, 2025

Eli Lilly vs. Viking Therapeutics Stock: Which Is the Best Growth Opportunity, According to Wall Street? - MSN

Oct 25, 2025

Oct 25, 2025

Is Viking Therapeutics Inc. forming a bottoming baseWeekly Risk Report & Entry and Exit Point Strategies - newser.com

Oct 25, 2025

Oct 25, 2025

Why Viking Therapeutics Inc. stock attracts high net worth investorsEarnings Summary Report & Daily Oversold Stock Bounce Ideas - newser.com

Oct 25, 2025

Oct 24, 2025

Leerink Partners Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $118 - 富途牛牛

Oct 24, 2025

Oct 24, 2025

JP Morgan Lowers Price Target for Viking Therapeutics (VKTX) to $75 | VKTX Stock News - GuruFocus

Oct 24, 2025

Oct 24, 2025

Viking Therapeutics, Inc. (NASDAQ:VKTX) Q3 2025 Earnings Call Transcript - Insider Monkey

Oct 24, 2025

Oct 24, 2025

Decoding Viking Therapeutics Inc (VKTX): A Strategic SWOT Insigh - GuruFocus

Oct 24, 2025

Oct 24, 2025

Viking Therapeutics Navigates Regulatory Risks Amid U.S. Policy Shifts - TipRanks

Oct 24, 2025

Oct 24, 2025

Viking Therapeutics (VKTX): Assessing Valuation After 36% Monthly Share Price Gain - simplywall.st

Oct 24, 2025

Oct 23, 2025

Viking Therapeutics’ Earnings Call: Clinical Success Amid Financial Challenges - TipRanks

Oct 23, 2025

Oct 23, 2025

Viking Bolts Higher; It's Moving At 'Lightning' Speed - Investor's Business Daily

Oct 23, 2025

Oct 23, 2025

Noteworthy Thursday Option Activity: VKTX, KODK, GEO - Nasdaq

Oct 23, 2025

Oct 23, 2025

Here's Why This Obesity Drug Company's Share Price Soared Today - AOL.com

Oct 23, 2025

Oct 23, 2025

Viking Therapeutics Posts Wider-Than-Expected Loss in Q3, Sales Nil - sharewise.com

Oct 23, 2025

Oct 23, 2025

Healthcare Stocks Show Mixed Moves As Companies Shift Strategies - Finimize

Oct 23, 2025

Oct 23, 2025

Why Is Viking Therapeutics Stock Rising Today? - Benzinga

Oct 23, 2025

Oct 23, 2025

Viking Therapeutics Stock Soars After Morgan Stanley’s Price Target Implies A Potential 225% Upside - Stocktwits

Oct 23, 2025

Oct 23, 2025

Viking Therapeutics Q3 Earnings: What We Learned (And Why We Should Keep Faith) (VKTX) - Seeking Alpha

Oct 23, 2025

Oct 23, 2025

MASH, Metsera Deals Send Analysts Marauding to Viking - BioSpace

Oct 23, 2025

Oct 23, 2025

Viking Therapeutics: The Prime Target In The Obesity Gold Rush (NASDAQ:VKTX) - Seeking Alpha

Oct 23, 2025

Oct 23, 2025

Viking Therapeutics stock price target raised by Cantor Fitzgerald on positive outlook - Investing.com

Oct 23, 2025

Oct 23, 2025

Viking Therapeutics (VKTX) Receives Updated Price Target from Mo - GuruFocus

Oct 23, 2025